Is there value in using randomized placebo controlled trials in neuromuscular disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is there value in using randomized placebo controlled trials in neuromuscular disease?

Published:2020-10-19 Issue:1 Volume:21 Page:5-7
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Bach John R.¹,Chiarello Giulio²,Weiss William³,Souayah Nizar⁴

Affiliation:

1. Department of Physical Medicine and Rehabilitation, Rutgers University – New Jersey Medical School, Center for Ventilator Management Alternatives and Pulmonary Rehabilitation of the University Hospital of Newark, Newark, NJ, USA

2. Department of Physical Medicine and Rehabilitation, Rutgers University – New Jersey Medical School, Newark, NJ, USA

3. Pulmonary Division, Department of Medicine, Conamaugh Memorial Medical Center, Johnstown, PA, USA

4. Department of Neurology, Rutgers University – New Jersey Medical School, Newark, NJ, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Clinical Neurology,General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2020.1834854

Reference18 articles.

1. A Study of Thyrotropin-Releasing Hormone for the Treatment of Spinal Muscular Atrophy

2. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain

3. Should we reconsider the routine use of placebo controls in clinical research?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Telemedicine in the management of patients with chronic respiratory failure;Breathe;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP